SBIR/STTR Research Award

STARLIGHT, The Next Generation X-ray Imaging Technology

Award identifier f1425dec01a7591b37e0c5c8362aca5d82fbc51a81b3d27a095dfd5411e31e6cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,942,984

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IMAGINE SCIENTIFIC INC
Proposal award date
2022-09-15
Contract end date
2024-08-31
UEI
LJ4JLBKM96E5
Solicitation number
PA20-260
Topic code
NCI

Research abstract

STARLIGHTTM, The Next Generation X-ray Imaging Technology ABSTRACTImagine Scientific has invented STARLIGHT, an IP-protected monochromatic X-ray source that will significantly improve medical imaging. It is a long-awaited engineering and scientific breakthrough, and the first practical, cost-effective, clinical source of monochromatic X-rays for diagnostic imaging. In its first clinical application, it will be used in X-ray mammography to considerably advance screening and diagnosis of breast cancer. Mammography systems using STARLIGHT will offer (i) superior detection of tumors for all women, including those with thick and dense breasts, (ii) significantly lower radiation dose, (iii) elimination of painful breast compression during examinations, and (iv) chemical analysis of tissue in-vivo.Breast cancer is the most common cancer in women, with over 260,000 new cases diagnosed each year in the US. 1 in 8 women will develop invasive breast cancer during their lifetime. 40%-50% of women have dense breasts (BI-RAD categories 3 and 4 - high proportion of glandular and fibrous tissue), increasing their risk of developing cancer by 4 to 6 times. The detection sensitivity level for these women is 48%-64%, compared to ~ 85% for women with less glandular and low amounts of fibrous breast tissue (BI-RAD categories 1 and 2).STARLIGHT addresses unmet women’s health needs caused by the performance limitations of current mammography systems. Mammography systems using monochromatic X-rays will improve detection sensitivity for early-stage cancers in the ~45 million women screened each year (US). Higher sensitivity will reduce the number of missed diagnoses of cancer, while higher specificity will considerably lower the number of false positive cancer detections and the unnecessary resulting biopsies, referrals for adjuvant ultrasound and MRI scans, and avoidable costs and high stress levels for affected patients. In addition to a more conclusive diagnosis, women screened with STARLIGHT-based mammography systems will receive considerably lower radiation dose and experience breast exams without undergoing painful breast compression. Monochromatic mammography’s superior performance is expected to substantially reduce morbidity associated with misdiagnosed or late-diagnosed breast cancer.STARLIGHT is the first technology capable of producing selectable, monochromatic X-rays with the required intensity for full-field mammography and can be integrated into conventional 2-D and 3-D mammography systems. The cost to manufacture a STARLIGHT-based mammography system is expected to be similar to current commercial machines.Imagine Scientific will design, fabricate and build an advanced STARLIGHT monochromatic X-ray source with at least 10 times the intensity of the current prototype, enabling exposure times between 1 and 7 seconds. It will be installed in a commercial mammography system, to demonstrate superior image quality and lower radiation doses compared to current mammography systems.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2022–2025). Reported award amounts total $2,722,642. Reported amounts are not federal obligations.

Phases: Phase II – Direct to Phase II, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.